StockData

Quantum Cyber vs YD Bio

QUCY and YDES side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How QUCY and YDES compare

YD Bio grew revenue faster over the last twelve months (16.9% versus −39.9% for Quantum Cyber).

YD Bio keeps more of each dollar of sales as profit, with a net margin of −1393% compared with −3018% at Quantum Cyber.

YD Bio scores higher on the StockData Score (5 against 3 for Quantum Cyber), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricQUCYYDES
Size and price
Share price$0.580$4.73
Change, 1 year−60.3%−61.4%
Change, 5 years−94.1%−53.5%
Beta (5Y)2.15−0.59
Employees313
StockData Score
Total score35 (better)
Valuation score00
Growth score1 (better)0
Performance score1 (better)0
Health score15 (better)
Dividend score00
Growth
Revenue growth (TTM)−39.9%16.9% (better)
Revenue growth, 5Y average1.7%–
Profitability
Gross margin72.6% (better)28.1%
Operating margin−3005%−883% (better)
Net margin−3018%−1393% (better)
FCF margin−2045%−1347% (better)
Return on equity−141% (better)−174%
Return on invested capital−324%−130% (better)
Financial health
Debt / equity–0.00
Interest coverage−43.2×–
Current ratio5.56 (better)5.23
Piotroski F-score22
Ownership
Held by institutions2.4%–
Held by insiders–92.8%
Insider net buying, 12 months$0$129K (better)

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.